Propanc Biopharma, Inc.
Developing proenzyme therapies to prevent solid tumor recurrence and metastasis.
PPCB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74346N4043
- LEI:
- Country:
- United States of America
- Address:
- 302/6 BUTLER STREET, 3124 CAMBERWELL, VICTORIA
- Website:
- https://www.propanc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Propanc Biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in the research and development of novel cancer treatments. The company focuses on preventing the recurrence and metastasis of solid tumors, particularly for patients with pancreatic, ovarian, and colorectal cancers. Its lead product candidate, PRP, is a pancreatic proenzyme formulation designed to suppress tumor cell migration, inhibit blood vessel formation within tumors, and induce cancer cell death. Propanc's goal is to develop an effective and well-tolerated therapy suitable for long-term, chronic use in cancer management.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Propanc Biopharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Propanc Biopharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Propanc Biopharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
